Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72603-282

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72603-282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Atorvastatinfigure1 (Atorvastatinfigure1)
Chemical structure of atorvastatin calcium showing its molecular arrangement, including calcium ion complexation with three water molecules.*
FDA Label Image

Atorvastatintablets10mg90scontainerlabel (Atorvastatintablets10mg90scontainerlabel)

Atorvastatintablets10mg90scontainerlabel (Atorvastatintablets10mg90scontainerlabel)
Label for Atorvastatin Calcium Tablets, USP 10 mg oral film-coated tablets, with a bottle count of 90 tablets. Manufactured for NorthStar Rx LLC, Memphis, TN, and by Annora Pharma Pvt. Ltd., India. The label includes storage instructions, dosage notation, barcode, and manufacturing details.*
FDA Label Image

Atorvastatintablets20mg90scontainerlabel (Atorvastatintablets20mg90scontainerlabel)

Atorvastatintablets20mg90scontainerlabel (Atorvastatintablets20mg90scontainerlabel)
Label for Atorvastatin Calcium Tablets, USP 20 mg film-coated oral tablets, 90 count. The label states the product is manufactured by Annora Pharma Pvt. Ltd. for Northstar Rx LLC and includes storage instructions and dosage advisory. The label also displays the NDC 72603-283-01 and a barcode.*
FDA Label Image

Atorvastatintablets40mg90scontainerlabel (Atorvastatintablets40mg90scontainerlabel)

Atorvastatintablets40mg90scontainerlabel (Atorvastatintablets40mg90scontainerlabel)
Label for Atorvastatin Calcium Tablets, USP 40 mg, film-coated oral tablets. The label displays the product name and strength prominently, with storage instructions at 20° to 25°C. It indicates a package size of 90 tablets, manufactured for Northstar Rx LLC, Memphis, TN, and produced by Annora Pharma Pvt. Ltd., India. The label includes an NDC code and a barcode.*
FDA Label Image

Atorvastatintablets80mg90scontainerlabel (Atorvastatintablets80mg90scontainerlabel)

Atorvastatintablets80mg90scontainerlabel (Atorvastatintablets80mg90scontainerlabel)
Label for Atorvastatin Calcium Tablets, USP 80 mg by NorthStar Rx LLC. The film-coated tablet packaging contains 90 tablets. The label includes storage instructions, manufacturer details (Annora Pharma Pvt. Ltd., India), barcode, and lot information with an expiration date of June 2024. The label also notes dispensing guidelines and dosage reference to package insert.*
FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
A line chart showing cumulative incidence (%) over time in years comparing Atorvastatin and Placebo. The y-axis represents cumulative incidence from 0.0 to 4.0%, and the x-axis spans from 0 to 3.5 years. The solid line represents Atorvastatin, and the dashed line represents Placebo, indicating lower cumulative incidence with Atorvastatin. The chart includes a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
A cumulative hazard curve chart depicting time to first primary endpoint over four years of follow-up, comparing Atorvastatin and placebo groups. The x-axis represents time in years, and the y-axis shows cumulative hazard percentage. Atorvastatin's curve is consistently lower than placebo's, with a hazard ratio and p-value noted on the graph.*
FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over 5 years for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years to first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78, 95% CI 0.69-0.89) and p-value of 0.0002, indicating statistical analysis of event rates between the two doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.